The Compensation Committee authorized the purchase of 94,000 shares of common stock under the 2023 Employment Inducement Incentive Award Plan. These options carry an exercise price of $36.74 per share, matching the closing market price on the date of the grant. The structure of the award includes a 10-year term and a four-year vesting schedule. One-quarter of the total options will vest on the first anniversary of the commencement date, with the remainder vesting in equal monthly installments over the following three years, contingent upon continued service to the firm.
In section Releases
IDEAYA Biosciences Issues Stock Options to New Hires
South San Francisco-based IDEAYA Biosciences has issued non-qualified stock options to three newly recruited employees as a material incentive for their hiring. The grant, finalized on September 24, 2026, aligns with Nasdaq Listing Rule 5635(c)(4) to support the company’s expansion in precision medicine oncology.
Comments (0)
No comments yet. Be the first!